Vimarsana
Biggest News Aggregation in the World

Page 3 - Cm Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cm Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cm Management Today - Breaking & Trending Today

AMCON Distributing (NYSEAMERICAN:DIT) Research Coverage Started at StockNews.com - Vimarsana News

AMCON Distributing (NYSEAMERICAN:DIT) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of AMCON Distributing (NYSEAMERICAN:DIT – Free Report) in a report released on Tuesday morning. The brokerage issued a hold rating on the stock. AMCON Distributing Stock Performance AMCON Distributing stock opened at $143.00 on Tuesday. The company has a debt-to-equity ratio of 1.07, a quick ratio of 1.02 and a […]

Pan American Silver (NYSE:PAAS) Given New $30.00 Price Target at CIBC - Vimarsana News

Pan American Silver (NYSE:PAAS) Given New $30.00 Price Target at CIBC

Pan American Silver (NYSE:PAAS – Get Free Report) (TSE:PAAS) had its price objective increased by research analysts at CIBC from $27.50 to $30.00 in a note issued to investors on Wednesday, BayStreet.CA reports. The brokerage currently has an “outperform” rating on the basic materials company’s stock. CIBC’s price target would indicate a potential upside of […]

Cytosorbents (NASDAQ:CTSO) Earns Hold Rating from Analysts at StockNews.com - Vimarsana News

Cytosorbents (NASDAQ:CTSO) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a report released on Saturday. The firm issued a hold rating on the medical research company’s stock. A number of other equities analysts have also weighed in on CTSO. HC Wainwright reaffirmed a neutral rating and issued a $1.00 target price on shares […]

Source: wkrb13.com
Leerink Partnrs Weighs in on Compass Therapeutics, Inc.'s Q2 2024 Earnings (NASDAQ:CMPX) - Vimarsana News

Leerink Partnrs Weighs in on Compass Therapeutics, Inc.'s Q2 2024 Earnings (NASDAQ:CMPX)

Compass Therapeutics, Inc. (NASDAQ:CMPX – Free Report) – Analysts at Leerink Partnrs upped their Q2 2024 earnings estimates for Compass Therapeutics in a research report issued on Monday, May 13th. Leerink Partnrs analyst A. Berens now anticipates that the company will post earnings of ($0.11) per share for the quarter, up from their prior estimate […]

Freeport-McMoRan (NYSE:FCX) Given New $54.00 Price Target at UBS Group - Vimarsana News

Freeport-McMoRan (NYSE:FCX) Given New $54.00 Price Target at UBS Group

Freeport-McMoRan (NYSE:FCX – Free Report) had its target price hoisted by UBS Group from $41.00 to $54.00 in a report released on Tuesday morning, Benzinga reports. The brokerage currently has a neutral rating on the natural resource company’s stock. Other research analysts also recently issued research reports about the company. HSBC increased their price target […]